Publication | Closed Access

Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan

HepatologyHepatitis CViral HepatitisReal-world Multicenter CohortAntiviral Drug DevelopmentHepatitisAntiviral TherapyChronic Viral InfectionAntiviral DrugMedicineEpidemiologyNs5a Direct-acting Antivirals